(3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide
C64H89N15O15S — CID 59524881
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide
(3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide (PubChem CID 59524881) has the molecular formula C64H89N15O15S and a molecular weight of 1340.57 g/mol. Its IUPAC name is (3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide.
Molecular Properties
| Compound Name | (3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide |
|---|---|
| PubChem CID | 59524881 |
| Molecular Formula | C64H89N15O15S |
| Molecular Weight | 1340.57 g/mol |
| Exact Mass | 1339.64 |
| IUPAC Name | (3R)-3-[(3S,6S,9S,11R,15S,20R,24S,25S,26S)-18-[[1-[5-[4-[2-[4-(cyclopentylmethyl)piperazin-1-yl]pyrimidin-5-yl]phenyl]-1,3,4-thiadiazol-2-yl]piperidin-4-yl]methylamino]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-(4-hydroxy-3-methoxyphenyl)ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-3-yl]-3-hydroxypropanamide |
| SMILES | COc1cc(C[C@@H](O)[C@@H]2NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H]([C@@H](C)O)NC(=O)C(NCC3CCN(c4nnc(-c5ccc(-c6cnc(N7CCN(CC8CCCC8)CC7)nc6)cc5)s4)CC3)C[C@@H](O)CNC(=O)[C@@H]3[C@@H](O)[C@@H](C)CN3C(=O)[C@H]([C@H](O)CC(N)=O)NC2=O)ccc1O |
| InChI | InChI=1S/C64H89N15O15S/c1-34-31-79-54(55(34)87)59(91)67-30-42(81)24-44(66-27-36-14-16-77(17-15-36)64-74-73-60(95-64)40-11-9-39(10-12-40)41-28-68-63(69-29-41)76-20-18-75(19-21-76)32-37-6-4-5-7-37)56(88)70-51(35(2)80)61(92)78-33-43(82)25-45(78)57(89)71-52(47(84)22-38-8-13-46(83)49(23-38)94-3)58(90)72-53(62(79)93)48(85)26-50(65)86/h8-13,23,28-29,34-37,42-45,47-48,51-55,66,80-85,87H,4-7,14-22,24-27,30-33H2,1-3H3,(H2,65,86)(H,67,91)(H,70,88)(H,71,89)(H,72,90)/t34-,35+,42+,43+,44?,45-,47+,48+,51-,52-,53-,54-,55-/m0/s1 |
| InChIKey | JEDWADFIESVXIK-ORRZRHHISA-N |
| XLogP | -2.41 |
| TPSA | 424.26 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 95 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1340.57 |
| LogP ≤ 5 | -2.41 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 24 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59524881 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.